Drug Trial Radar · NCT05660538
Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)
Last checked: Nov 20, 2026Latest source record: Jul 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
194
Actual
Start
Dec 20, 2022
Primary completion
Oct 12, 2023
Study completion Oct 25, 2023
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Dec 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating Painful DPN.
Conditions
- Diabetic Peripheral Neuropathy
Interventions
SuzetrigineDrug
Tablets for oral administration.
PregabalinDrug
Capsules for oral administration.
Placebo (matched to SUZ)Drug
Placebo matched to SUZ for oral administration.
Placebo (matched to pregabalin)Drug
Placebo matched to pregabalin for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Weekly Average of Daily Pain Intensity on a Numeric Pain Rating Scale (NPRS)Time frame: Baseline, At Week 12
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Synexus Clinical Research US - Birmingham
Birmingham, Alabama
Synexus Clinical Research US - Phoenix West
Phoenix, Arizona
Velocity Clinical Research - Banning
Banning, California
Long Beach Clinical Trials Services, Inc.
Long Beach, California
University Clinical Investigators
Tustin, California
Lynn Institute of the Rockies
Colorado Springs, Colorado
Fleming Island Center for Clinical Research
Fleming Island, Florida
AMR Fort Myers (The Clinical Study Center)
Fort Myers, Florida
Velocity Clinical Research - Hallandale Beach
Hallandale, Florida
Westside Center for Clinical Research
Jacksonville, Florida
Accel Research Sites - Tampa
Largo, Florida
Accel Research Sites - Maitland
Maitland, Florida
Suncoast Research Associates
Miami, Florida
Synexus - Orlando
Orlando, Florida
Synexus - The Villages
The Villages, Florida
Accel Research Sites - Neurostudies
Decatur, Georgia
Velocity Clinical Research - Boise (Advanced Clinical Research)
Meridian, Idaho
Healthcare Research Network - Chicago
Flossmoor, Illinois
Synexus Clinical Research - Evansville
Evansville, Indiana
AMR El Dorado
El Dorado, Kansas
AMR Newton
Newton, Kansas
AMR Wichita East, KS
Wichita, Kansas
Clinical Trials of America, LLC
Monroe, Louisiana
Brigham and Women's Hospital (BWH) - Translational Pain Research
Boston, Massachusetts
Boston Neuro Research Center, LLC
North Dartmouth, Massachusetts
Boston PainCare Center
Waltham, Massachusetts
Revival Research Institute
Dearborn, Michigan
StudyMetrix Research, LLC
City of Saint Peters, Missouri
Healthcare Research Network - Hazelwood
Hazelwood, Missouri
AMR Kansas City
Kansas City, Missouri
Synexus Clinical Research US - St. Louis
St Louis, Missouri
Synexus Clinical Research - Henderson
Henderson, Nevada
Hassman Research Institute
Berlin, New Jersey
Synexus Clinical Research- New York
New York, New York
Carolina Institute for Clinical Research
Fayetteville, North Carolina
Triad Clinical Trials
Greensboro, North Carolina
The Center for Clinical Research
Winston-Salem, North Carolina
Synexus - Cincinnati
Cincinnati, Ohio
Velocity Clinical Research - Cleveland
Cleveland, Ohio
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.